Genetic models of Alzheimer's disease and their psychopathological validity

Alzheimer's Reports

Volumn 2, Issue 4, 1999, Pages 199-208

  Richards, Sarah Jane ^a   Dunnett, Stephen B ^a,b  

^a Department of Medicine ^*  (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 22644451102     PISSN: 14616130     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (113)

1. Allsopp T (1993) Life and death in the nervous-system. Trends Neurosci 16, 1-3.
2. Arriagada PV, Growdon JH, Hedley-Whyte ET and Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42, 631-639.
3. Bales KR, Verina T, Dodel RC et al. (1997) Lack of apolipoprotein E dramatically reduces amyloid beta- peptide deposition. Nature Genet 17, 263-264.
4. Ball MJ, Shapiro MB and Rapoport SI (1989) Neuropathological relationships between Down syndrome and senile dementia of the Alzheimer's type. In The Neurobiology of Down Syndrome (ed. CJ Epstein) New York, Raven Press, pp. 35-58.
5. Bartus RT, Dean RL and Beer B (1980) Memory deficits in aged cebus monkeys and facilitation with central cholinomimetics. Neurobiol Aging 1, 145-152.
6. Beer J, Salbaum JM, Schlichtman E et al. (1991) Transgenic mice and Alzheimer's disease. In Alzheimer's disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies (eds. K Iqbal, DRC McLachlan, B Winblad and HM Wisniewski) John Wiley, New York, pp. 473-478.
7. Beeri R, Le Novere N, Mervis R et al. (1997) Enhanced hemicholinium binding and attenuated dendrite branching in cognitively impaired acetylcholinesterase transgenic mice. J Neurochem 69, 2441-2451.
8. Bernstein A and Breitman M (1989) Genetic ablation in transgenic mice. Molecular Biology & Medicine 6, 523-530.
9. Boggs SS (1990) Targeted gene modification for gene-therapy of stem cells. International Journal Of Cell Cloning 8, 80-96.
10. Bons N, Mestre N and Petter A (1991) Occurrence of neuritic plaques and neurofibrillary changes in the cerebral-cortex of aged lemurian primate. Compt Rendues Acad Sci 313, 213-219.
11. Borsolt DR, Ratovitski T, van Lare J et al. (1997) Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19, 939-945.
12. Bowen DM, Smith CB, White P and Davison AN (1976) Neurotransmitter related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99, 459-496.
13. Braak H and Braak E (1985) On areas of transition between entorhinal allocortex and temporal isocortex in the human brain - normal morphology and lamina-specific pathology in Alzheimer's disease. Acta Neuropathol 68, 325-332.
14. Brion JP (1990) Molecular pathology of Alzheimer amyloid and neurofibrillary tangles. Sem Neurosci 2, 89-100.
15. Cole G and Neal JW (1990) The brain in aged elephants. J Neuropathol Exp Neurol 49, 190-191.
16. Cork LC, Powers RE, Selkoe DJ et al. (1988) Neurofibrillary tangles and senile plaques in aged bears. J Neuropathol Exp Neurol 47, 629-641.
17. Coussons-Read ME and Crnic LS (1996) Behavioral assessment of the Ts65Dn mouse, a model for Down syndrome: Altered behavior in the elevated plus maze and open field. Behavior Genetics 25, 7-13.
18. Crawley JN (1999) Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res Interact 19027, 1-9.
19. Crawley JN, Belknap JK, Collins A et al. (1997) Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology (Berl) 132, 107-124.
20. Czech C, Lesort M, Tremp G et al. (1998) Characterization of human presenilin 1 transgenic rats: Increased sensitivity to apoptosis in primary neuronal cultures. Neuroscience 87, 325-336.
21. D'Amato MR (1973) Delayed matching and short-term memory in monkeys. Psychol Learn Motiv 7, 227-269.
22. da Silva HAR and Patel AJ (1997) Presenilins and early-onset familial Alzheimer's disease. NeuroReport 9, R1-R12.
23. Davies CA, Mann DMA, Sumpter PQ and Yates PO (1987) A quantitative morphometric analysis of the neuronal and synaptic content of frontal and temporal cortex in patients with Alzheimer's disease. J Neurol Sci 78, 151-164.
24. Davies DC, Horwood N, Isaacs SL and Mann DMA (1992) The effect of age and Alzheimer's disease on pyramidal neuron density in the individual fields of the hippocampal formation. Acta Neuropathol 83, 510-517.
25. Davies P, Katzman R and Terry RD (1980) Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer's disease and Alzheimer senile dementia. Nature 288, 279-280.
26. DeKosky ST and Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease - correlation with cognitive severity. Ann Neurol 27, 457-464.
27. De Strooper B, Beullens M, Contreras B et al. (1997) Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease -associated presenilins. J Biol Chem 272, 3590-3598.
28. Doan A, Thinakaran G, Borchelt DR et al. (1996) Protein topology of presenilin 1. Neuron 17, 1023-1030.
29. Dunnett SB (1992) Aging, memory, and cholinergic systems: studies using delayed- matching and delayed-nonmatching tasks in rats. In: Neuropsychology of Memory (eds. LR Squire and N Butters) Guilford Press, New York, pp. 357-377.
30. Dunnett SB, Evenden JL and Iversen SD (1988) Delay-dependent short-term memory deficits in aged rats. Psychopharmacology (Berl) 96, 174-180.
31. Finger S, Heavens RP, Sirinathsinghji DJS et al. (1988) Behavioral and neurochemical evaluation of a transgenic mouse model of Lesch-Nyhan syndrome. J Neurol Sci 86, 203-213.
32. Fox N (1999) Magnetic Resonance Imaging in Alzheimer's disease: from diagnosis to measuring therapeutic effect. Alzheimer's Reports 2, 5-12.
33. Galaski D, Klauber MR, Hofstetter R et al. (1990) The mini-mental state examination in the early diagnosis of Alzheimer's disease. Arch Neurol 47, 49-52.
34. Games D, Adams D, Alessandrini R et al. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V71F β-amyloid precursor protein. Nature 373, 523-527.
35. Gerlai R (1996b) Gene targeting studies of mammalian behavior: Is it the mutation or the background genotype? Trends Neurosci 19, 177-181.
36. Gerlai R (1996a) Molecular genetic analysis of mammalian behavior and brain processes: Caveats and perspectives. Sem Neurosci 8, 153-161.
37. Giaccone G, Verga L, Finazzi M et al. (1990) Cerebral preamyloid deposits and congophilic angiopathy in aged dogs. Neurosci Lett 114, 178-183.
38. Hodos W (1970) Evolutionary interpretation of neuronal and behavioral studies of living vertebrates. In The Neurosciences: Second Study Program (ed. FO Schmitt) Rockefeller University Press, New York, pp. 28-39.
39. Hogan B, Constantini F and Lacey E (1986) Manipulating the Mouse Embryo. A Laboratory Manual. Cold Spring Harbor Press, Cold Spring Harbor, NY.
40. Holcomb L, Gordon MN, McGowan E et al. (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nature Med 4, 97-100.
41. Holtzman DM, Li YW, Dearmond SJ et al. (1992) Mouse model of neurodegeneration: atrophy of basal forebrain cholinergic neurons in trisomy 16 transplants. Proc Natl Acad Sci USA 89, 1383-1387.
42. Holtzman DM, Santucci D, Kilbridge J et al. (1996) Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc Natl Acad Sci USA 93, 13333-13338.
43. Hsiao K, Chapman P, Nilsen S et al. (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99-102.
44. Hyman BT, Vanhoesen GW and Damasio AR (1987) Alzheimer's disease - glutamate depletion in the hippocampal perforant pathway zone. Ann Neurol 22, 37-40.
45. Hyman BT, Vanhoesen GW and Damasio AR (1990) Memory-related neural systems in Alzheimer's disease - an anatomic study. Neurology 40, 1721-1730.
46. Irle E, Kessler J, Markowitsch H J and Hofmann W (1987) Primate learning tasks reveal strong impairments in patients with presenile or senile dementia of the Alzheimer type. Brain and Cognition 6, 429-449.
47. Iwatsubo T, Odaka A, Suzuki N et al. (1994) Visualization of Aβ-42(43) And Aβ-40 in senile plaques with end-specific Aβ-monoclonals - evidence that an initially deposited species is Aβ-42(43). Neuron 13, 45-53.
48. James NO, Davis DR, Sindon J et al. (1999) Neurodegenerative changes including altered tau phosphorylation and neurofilament immunoreactivity in mice transgenic for the serine threonine kinase Mos. Neurobiol Aging 17, 235-241.
49. Johnson SA, McNeill T, Cordell B and Finch CE (1990) Relation of neuronal APP 751/APP 695 messenger-RNA ratio and neuritic plaque density in Alzheimer's disease. Science 248, 854-857.
50. Kang J, Lemaire H.-G, Unterbeck A et al. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736.
51. Katzman R (1997) The aging brain - Limitations in our knowledge and future approaches. Arch Neurol 54, 1201-1205.
52. Kayyali US, Zhang W, Yee AG, Seidman JG and Potter H (1999) Cytoskeletal changes in the brains of mice lacking calcineurin A alpha. J Neurochem 68, 1668-1678.
53. Kelley WN and Wyngaarden JB (1983) Clinical syndromes associated with hypoxanthine-guanine phosphoribosyl transferase deficiency. In The Metabolic Basis of Inherited Disease (eds. JB Stanburry, JB Wyngaarden, DS Frederickson, JL Goldstein and MS Brown), McGraw-Hill, New York, pp. 1115-1143.
54. Koski K and Coleman P (1992) Is β-amyloid neurotoxic? Neurobiol Aging 13, 535-625.
55. Kowall NW and Beal MF (1991) Glutamate-immunoreactive, glutaminase-immunoreactive, and taurine-immunoreactive neurons develop neurofibrillary tangles in Alzheimer's disease. Ann Neurol 29, 162-167.
56. Kowall NW, McKee AC, Yankner BA. and Beal MF (1992) In vivo neurotoxicity of beta amyloid [β(1-40)] and the β(25-35) fragment. Neurobiol Aging 13, 537-542.
57. Kuehn MR, Bradley A, Robertson EJ and Evans MI (1987) A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature 326, 295-298.
58. Lane N J, Balbo A, Stoll J and Rapoport S (1994) Long-term intracerebral transplants of fetal hippocampus from mouse trisomy 16, a model of Down syndrome (trisomy 21), do not exhibit Alzheimer's disease neuropathology by ultrastructural criteria. Tissue Cell 26, 477-488.
59. Levy-Lahad E, Wasco W, Poorkaj P et al. (1995) Candidate gene for the chromosome-1 familial Alzheimer's disease locus. Science 269, 973-977.
60. Mann DMA, Iwatsubo T, Nochlin D et al. (1997) Amyloid (Aβ) deposition in chromosome 1-linked Alzheimer's disease: The Volga German families. Ann Neurol 41, 52-57.
61. Mann DMA, Younis N, Jones D and Stoddart RW (1992) The time course of pathological events in Down's syndrome with particular reference to the involvement of microglial cells and deposits of β/A4. Neurodegeneration 1, 201-215.
62. Masliah E (1998) Mechanisms of synaptic pathology in Alzheimer's disease. J Neural Transm Suppl 147-158.
63. Masliah E, Sisk A, Mallory M et al. (1996) Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease. J Neurosci 16, 5795-5811.
64. Masters CL, Simms G, Weinmann NA et al. (1985) Amyloid plaque core protein in Alzheimer's disease and Down's syndrome. Proc Natl Acad Sci USA 82, 4245-4249.
65. Mena R, Edwards PC, Harrington CR, Mukaetova-Ladinska EB and Wischik CM (1996) Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer's disease. Acta Neuropathol 91, 633-641.
66. Mirra SS, Hart MN and Terry RD (1993) Making the diagnosis of Alzheimer's disease - a primer for practicing pathologists. Archives of Pathology & Laboratory Medicine 117, 132-144.
67. Morris RGM (1981) Spatial localisation does not depend on the presence of local cues. Learn Motiv 12, 239-260.
68. Morris RGM, Garrud P, Rawlins JNP and O'Keefe J (1982) Place navigation impaired in rats with hippocampal lesions. Nature 297, 681-683.
69. Multhaup G, Masters CL and Beyreuther K (1998) Oxidative stress in Alzheimer's disease. Alzheimer's Reports 1, 147-154
70. Murayama M, Tanaka S, Palacino J et al. (1998) Direct association of presenilin-1 with beta-catenin. FEBS Letters 443, 73-77.
71. Nabeshima T and Itoh A (1997) Alzheimer's disease animal models induced by continuous infusion of beta-amyloid protein and anti-nerve growth factor antibody. Rev Heteroatom Chem 16, 229-255.
72. Oliver C and Holland A (1986) Down syndrome and Alzheimer's disease: a review. Psychol Med 16, 307-322.
73. Olton DS and Wenk GL (1987) Dementia: animal models of the cognitive impairments produced by degeneration of the basal forebrain cholinergic system. In Psychopharmacology: The Third Generation of Progress (ed. HY Meltzer) Raven Press, New York, pp. 941-953.
74. Oscar-Berman M and Bonner RT (1989) Nonmatching- (oddity) and delayed nonmatching-to-sample performance in aging, alcoholic, and alcoholic Korsakoff individuals. Psychobiology 17, 424-430.
75. Pearson RCA, Esiri MM, Hiorns RW, Wilcock GK and Powell TPS (1985) Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc Natl Acad Sci USA 82, 4531-4534.
76. Pearson RCA and Powell TPS (1989) The neuroanatomy of Alzheimer's disease. Rev Neurosci 2, 101-122.
77. Perry G, Cras P, Siedlak SL, Tabaton M and Kawai M (1992) β-Protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease. Am J Pathol 140, 283-290.
78. Perry TA, Torres EM, Czech C et al. (1995) Cognitive and motor function in transgenic mice carrying excess copies of the 695 and 751 amino acid isoforms of the amyloid precursor protein gene. Alz Res 1, 5-14.
79. Podlisny MB, Stephenson DT, Frosch MP et al. (1992) Synthetic β-amyloid fails to produce specific neurotoxicity in monkey cerebral cortex. Neurobiol Aging 13, 561-567.
80. Quon D, Wang Y, Catalano R et al. (1991) Formation of β-amyloid protein deposits in brains of transgenic mice. Nature 352, 239-241.
81. Reeves RH, Irving NG, Moran TH et al. (1995) A mouse model for Down syndrome exhibits learning and behavior deficits. Nature Genet 11, 177-184.
82. Richards SJ, Edwards P, Waters JJ, Torres EM and Dunnett SB (1993) Ultrastructural neuropathology in murine trisomy 16 hippocampal grafts. NeuroReport 4, 208-210.
83. Richards SJ, Waters JJ, Beyreuther K et al. (1991) Transplants of mouse trisomy 16 hippocampus provide a model of Alzheimer's disease neuropathology. EMBO J 10, 297-303.
84. Robakis NW, Wisniewski HM, Jenkins EC et al. (1987) Chromosome 21q21 sublocalisation of gene encoding β-amyloid peptide in cerebral vessels and neurite (senile) plaques of people with Alzheimer disease and Down syndrome. Lancet i, 384-385.
85. Roberts AC and Sahakian BJ (1993) Comparable tests of cognitive function in monkey and man. In Behavioural Neuroscience: A Practical Approach (ed. A Sahgal), IRL Press, Oxford, pp. 165-184.
86. Roth M, Tomlinson BE and Blessed G (1967) The relationship between measures of dementia and of degenerative changes in the cerebral grey matter of elderly subjects. Proc Roy Soc Lond B 60, 254-259.
87. Sago H, Carlson EJ, Smith DJ et al. (1998) Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc Natl Acad Sci USA 95, 6256-6261.
88. Sahakian BJ, Morris RG, Evenden JL et al. (1988) A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. Brain 111, 695-718.
89. Scheper W, Annaert W, Cupers P, Saftig P and De Strooper B. (1999) Function and dysfunction of the presenilins. Alzheimer's Reports 2, 73-81.
90. Sherrington R, Rogaev El, Liang Y et al. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimers-disease. Nature 375, 754-760.
91. Stahl T, Goldammer A, Luschekina E et al. (1998) Long-term basal forebrain cholinergic-rich grafts derived from trisomy 16 mice do not develop β-amyloid pathology and neurodegeneration but demonstrate neuroinflammatory responses. Int J Dev Neurosci 16, 763-775.
92. Sturchler-Pierrat C and Sommer B (1999) Transgenic animals in Alzheimer's disease research. Rev Neurosci 10, 15-24.
93. Su Y and Ni BH (1998) Selective deposition of amyloid β protein in the entorhinal-dentate projection of a transgenic mouse model of Alzheimer's disease. J Neurosci Res 53, 177-186.
94. Suzuki N, Cheung TT, Cai XD et al. (1994) An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (β-APP(717)) mutants. Science 264, 1336-1340.
95. Takashima A, Murayama M, Murayama O et al. (1998) Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. Proc Natl Acad Sci USA 95, 9637-9641.
96. Terry RD and Katzman R (1983) Senile dementia of the Alzheimer type. Ann Neurol 14, 497-506.
97. Terry RD, Masliah E, Salmon DP et al. (1991) Physical basis of cognitive alterations in Alzheimer's disease - synapse loss is the major correlate of cognitive impairment. Ann Neurol 30, 572-580.
98. Terry RD, Peck A, DeTeresa R, Schechter R and Horoupian DS (1981) Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 10, 184-192.
99. Terry RD and Wisniewsk HM (1970) The ultrastructure of the neurofibrillary tangle and the senile plaque. In Alzheimer's Disease and Related Conditions (ed. CIBA Foundation Symposia) Churchill, London, pp. 145-168.
100. Tomlinson BE (1999) Ageing and the dementias.' In Greenfield's Neuropathology (eds. JH Adams and LW Duchen), Oxford University Press, New York, pp. 1284-1410.
101. Von Koch CS, Zheng H, Chen H et al. (1997) Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice. Neurobiol Aging 18, 661-669.
102. Walker LC, Kitt CA, Struble R et al. (1988) The neural basis of memory decline in aged monkeys. Neurobiol Aging 9, 657-666.
103. Whishaw IQ, Mittleman G, Bunch S and Dunnett SB (1987) Impairments in the acquisition, retention and selection of spatial navigation strategies after medial caudate-putamen lesions in rats. Behav Brain Res 24, 125-138.
104. Whitehouse PJ, Price DL, Struble RG et al. (1982) Alzheimer's disease and senile dementia - loss of neurons in the basal forebrain. Science 215, 1237-1239.
105. Wisniewski HM, Ghetti B and Terry RD (1973) Neuritic (senile) plaques and filamentous changes in aged rhesus monkeys. J Neuropathol Exp Neurol 32, 566-584.
106. Wisniewski HM, Wegiel J, Wang KC, Kujawa M and Lach B (1989) Ultrastructural studies of the cells forming amyloid fibers in classical plaques. Can J Neurol Sci 16, 535-542.
107. Wisniewski KE, Wisniewski HM and Wen GY (1985) Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down syndrome. Ann Neurol 17, 278-282.
108. Yamaguchi F, Richards SJ, Beyreuther K et al. (1991) Transgenic mice for the amyloid precursor protein 695 isoform have impaired spatial memory. NeuroReport 2,781-784.
109. Yankner BA, Caceres A and Duffy LK (1990) Nerve growth factor potentiates the neurotoxicity of beta-amyloid. Proc Natl Acad Sci USA 87, 9020-9023.
110. Yankner BA, Dawes LR, Fisher S et al. (1989) Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245, 417-420.
111. Yankner BA and Mesulam MM (1991) β-Amyloid and the pathogenesis of Alzheimer's disease. New Engl J Med 325, 1849-1857.
112. Yu G, Chen F, Levesque G et al. (1998) The presenilin1 protein is a component of high molecular weight intracellular complex that contains beta-catenin. J Biol Chem 273, 16470-16475.
113. Zheng H, Jiang MH, Trumbauer ME et al. (1995) Beta-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell 81, 525-531.